SCHEMBL6483103

SCHEMBL6483103

CCCCOC(=O)C[S+]([O-])c1nc2cccnc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 1/20 0.39
NFKB1 P19838 1/20 0.39
CYP2C19 P33261 1/20 0.39
STAT1 P42224 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 5/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP2C9 P11712 1/20 0.38
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9214938 0.96 NPC1 (0.41) NPC1ALDH1A1CYP1A2NFKB1CYP2C19
SCHEMBL9206863 0.93 POLB (0.40) NPC1ALDH1A1RAB9ATP53MAPT
SCHEMBL9208328 0.89 CYP2C9 (0.44) NPC1ALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL9212542 0.84 POLB (0.43) NPC1ALDH1A1RAB9ATP53MAPT
SCHEMBL9206988 0.83 GAA (0.39) NPC1ALDH1A1RAB9ATP53MAPT
SCHEMBL9218741 0.82 MAPT (0.44) NPC1ALDH1A1CYP1A2CYP2C19RAB9A
SCHEMBL9208265 0.82 CYP2C9 (0.35) NPC1ALDH1A1RAB9ATP53MAPT
SCHEMBL9208256 0.82 CYP2C9 (0.35) NPC1ALDH1A1RAB9ATP53MAPT
SCHEMBL9216332 0.81 PDK1 (0.35) NPC1ALDH1A1STAT1RAB9ASMN1; SMN2
SCHEMBL9211255 0.81 POLB (0.38) NPC1ALDH1A1RAB9ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5945425-A ADENOSINE TRIPHOSPHASE INHIBITOR; DNA VIRICIDE G.D. SEARLE & CO. (US) 1999-08-31 US claimed
EP-0405976-B1 Azole derivatives and antiulcerative composition containing same MEIJI SEIKA CO (JP) 1995-04-05 EP claimed
US-5079255-A Nontoxic, acid stability MEIJI SEIKA KABUSHIKI KAISHA (JP) 1992-01-07 US claimed
EP-0405976-A1 Azole derivatives and antiulcerative composition containing same MEIJI SEIKA KABUSHIKI KAISHA (JP) 1991-01-02 EP claimed
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed
US-6906078-B2 Method of using (H+/K+) ATPase inhibitors as antiviral agents PHARMACIA CORPORATION (US) 2005-06-14 US disclosed
EP-0673246-A1 USE OF ALKYLTHIOPYRIDINES FOR CONTROLLING HELICOBACTER BACTERIA Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1995-09-27 EP disclosed
EP-0405976-B1 Azole derivatives and antiulcerative composition containing same MEIJI SEIKA CO (JP) 1995-04-05 EP disclosed
WO-1994013290-A1 USE OF ALKYLTHIOPYRIDINES FOR CONTROLLING HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1994-06-23 WO disclosed
US-5200407-A Antisecretory agents MEIJI SEIKA KABURHIKI KAISHA (JP) 1993-04-06 US disclosed
US-5141946-A Antisecretory agents; acid resistance MEIJI SEIKA KABUSHIKI KAISHA (JP) 1992-08-25 US disclosed
US-5079255-A Nontoxic, acid stability MEIJI SEIKA KABUSHIKI KAISHA (JP) 1992-01-07 US disclosed